Sean C. Flynn, Chief Legal Officer of Vericel Corp (NASDAQ:VCEL), filed a Form 4 on November 6, 2026, disclosing the exercise of 15,000 stock options and the same-day sale of 15,000 shares of common stock on November 5, 2026.

Key Highlights

  • Option exercise: Flynn exercised 15,000 stock options at an exercise price of $16.25 per share on November 5, 2026, via transaction code M.
  • Share sale: 15,000 shares of common stock were disposed of at $51.92 per share on November 5, 2026, via transaction code S.
  • 10b5-1 plan: According to the filing, the sales "were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025."
  • Remaining beneficial ownership: Following the transactions, Flynn directly beneficially owned 1,990 shares of common stock.
  • Remaining options: Flynn holds 40,000 stock options (right to buy) with an exercise price of $16.25 and an expiration date of November 4, 2029.
  • ESPP note: The filing states that reported share totals include shares acquired under the issuer's 2015 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(d) and Rule 16b-3(c).

Flynn's Option Exercise and Planned Sale at Vericel Corp

Sean C. Flynn, serving as Chief Legal Officer of Vericel Corp, reported two transactions on November 5, 2026, in a Form 4 filed with the SEC. First, Flynn exercised 15,000 stock options at an exercise price of $16.25 per share, acquiring 15,000 shares of common stock. These options had an expiration date of November 4, 2029, according to the filing.

On the same date, Flynn disposed of 15,000 shares at a price of $51.92 per share. The filing attributes this sale to "an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025." The filing also indicates, via the checked box, that the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Following both transactions, Flynn's direct beneficial ownership in Vericel Corp common stock stood at 1,990 shares, the filing disclosed. Additionally, Flynn retains 40,000 stock options with the right to purchase common stock at $16.25 per share, expiring November 4, 2029. The filing notes that those options became exercisable on November 4, 2020, with 25% vesting on that first anniversary date and the remaining 75% vesting in equal quarterly installments over three years, contingent upon continued service to the company.

What Was Disclosed

The filing reports a same-day option exercise and share sale by Vericel Corp's Chief Legal Officer on November 5, 2026, executed under a pre-established Rule 10b5-1 trading plan adopted December 2, 2025, leaving Flynn with direct ownership of 1,990 shares.